, Inc. (AMZN) Kindle Fire Caught Fire This Year?

Page 1 of 2 Inc (AMZN), Inc. (NASDAQ:AMZN) made quite a hubbub over its new line of Kindle Fire HD devices in the fall as part of the company’s ramp-up to the holiday shopping season. And it appeared that the launch and low price point of the device, compared to Apple Inc. (NASDAQ:AAPL)‘s iPad, made a bit of a dent in Apple’s tablet marketshare positioning.

Mobile ad firm Chitika loves to survey Web traffic on various mobile devices, and its regular survey of ad impressions originating from certain devices came out for the dates of December 1 through December 27. The survey noted some interesting trends once Christmas passed.

Post-Christmas, all iPad models (including the iPad Mini, which was introduced as a direct competitor to the Kindle Fire) lost more than seven percentage points in market share, from 86 percent down to 78.9 percent (an overall drop of eight percent).

On the other hand,, Inc. (NASDAQ:AMZN) seemed to be a big gainer, as its Kindle Fire market share jumped by three percentage points to about 7.5 percent of all tablets. The Galaxy by Samsung increased its market share to nearly 4.5 percent, and the Nexus tablet by Google Inc. (NASDAQ:GOOG) posted a post-holiday gain of just north of 2 percent of market share.

“The tablet which brought the product category into the mainstream, Apple’s product has long been the king of the market. However, this Christmas marked a serious diversification in tablet shares,” according to Chitika’s report. The report went on to say, however, that Chitika fully expects Apple to return to the 80-percent mark in market share in pretty short order.

However, the report does show that, Inc. (NASDAQ:AMZN) made some progress in other areas this holiday season.

Continue reading to check it out…

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!